Furthermore, as regard the willingness to receive the PSA-test as a main screening test for prostate cancer prevention, approximately little more than half (59.4%) responded ‘‘yes” on being asked about willingness to receive the PSA-test. The gene discussed is KLK3; the disease is prostate cancer.